These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 3465582)

  • 1. Adjustment of intravenous theophylline dosage according to serum concentration on admission and total body clearance.
    Laaban JP; Dupeyron JP; Guyon F; Lafay M; Drieu L; Rochemaure J; Fabiani P
    Eur J Respir Dis Suppl; 1986; 146():571-9. PubMed ID: 3465582
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intravenous theophylline: adaptation of dosage to blood theophylline levels at admission and to clearance].
    Laaban JP; Dupeyron JP; Guyon F; Drieu L; Rochemaure J; Fabiani P
    Ann Med Interne (Paris); 1986; 137(5):415-9. PubMed ID: 3813276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid estimation of total body clearance of theophylline in patients receiving intravenous aminophylline infusion.
    Lau AH; O'Connor T; Lam G; Lui CY; Al-Bazzaz FJ; Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):12-5. PubMed ID: 3957483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early estimate of theophylline clearance during intravenous infusion.
    Rizzo A; Mirabella A; Ferrara G; Mangiacavallo A; Bonanno A; Bonsignore G
    Eur J Respir Dis; 1986 Apr; 68(4):291-7. PubMed ID: 3732424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Theophylline: pharmacokinetic parameters and determination of an efficient individual dosage (author's transl)].
    Blaive B; Lapalus P; Lemoigne F; Bugnas B
    Bull Eur Physiopathol Respir; 1981; 17(3):333-9. PubMed ID: 7248556
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oral theophylline therapy for dyspnea].
    Branick M; Beier W; Lanser K
    Fortschr Med; 1984 Apr; 102(13):379-82. PubMed ID: 6724467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-over study of oral and intravenous administration of theophylline in male volunteers. Absolute bioavailability of theophylline tablets.
    Kaumeier HS; Kehrhahn OH; Neugebauer G; Schuppan D; Schwarz JA; Staib AH
    Arzneimittelforschung; 1984; 34(1):92-5. PubMed ID: 6538428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of theophylline clearance using condition correction factors.
    Haumschild MJ; Murphy JE
    Clin Pharm; 1985; 4(1):59-64. PubMed ID: 3971684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Chiou method for determining theophylline dosages.
    Johnson MH; Burkle WS
    Clin Pharm; 1984; 3(2):174-8. PubMed ID: 6723223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the "condition correction factor" method of estimating theophylline clearance.
    Gotz VP; Russell WL; Lopez LM
    Ther Drug Monit; 1983; 5(1):103-7. PubMed ID: 6845393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route].
    Albertini M; Lapalus P; Maurin S; Boutte P; Mariani R
    Arch Fr Pediatr; 1982 Nov; 39(9):671-5. PubMed ID: 7165461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A crossover study after oral and intravenous administration of theophylline in male volunteers (absolute bioavailability of Afonilum tablets).
    Kaumeier HS; Kehrhahn OH; Neugebauer G; Schuppan D; Schwarz JA; Staib AH
    Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):339-45. PubMed ID: 6885204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of 11 methods for predicting theophylline dose.
    Rodvold KA; Paloucek FP; Zell M
    Clin Pharm; 1986 May; 5(5):403-8. PubMed ID: 3720210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical grand rounds. Theophylline pharmacokinetics.
    Kossmann CE
    J Tenn Med Assoc; 1984 Apr; 77(4):206-12. PubMed ID: 6727342
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug monitoring: theophylline--comparison of 3 methods for determination].
    Kropp R; Göbel D
    Pneumologie; 1995 Feb; 49(2):60-4. PubMed ID: 7724504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting theophylline pharmacokinetics in premature infants with apnea.
    Hilligoss DM; Jusko WJ; Koup JR; Giacoia G
    Dev Pharmacol Ther; 1980; 1(1):6-15. PubMed ID: 7438966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a single-point method for predicting theophylline dosage.
    McGory RW; Matzke GR
    Clin Pharm; 1982; 1(5):441-6. PubMed ID: 7184675
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bioavailability of theophylline after oral administration of a retard preparation of theophylline-ethylenediamine and the influence of 15-day ingestion on elimination kinetics after i.v. injection (author's transl)].
    Wiessmann KJ
    Arzneimittelforschung; 1980; 30(2):329-32. PubMed ID: 7378114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in theophylline clearance during acute illness.
    Vozeh S; Powell JR; Riegelman S; Costello JF; Sheiner LB; Hopewell PC
    JAMA; 1978 Oct; 240(17):1882-4. PubMed ID: 691199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of theophylline population pharmacokinetics in adult hospitalized patients using NONMEM analysis].
    Li Z; Chen G
    Zhongguo Yao Li Xue Bao; 1994 May; 15(3):267-70. PubMed ID: 7976385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.